Renal failure after clinical heart transplantation is associated with the TGF-β1 codon 10 gene polymorphism

Journal of Heart and Lung Transplantation

Volumn 19, Issue 9, 2000, Pages 866-872

  Baan, Carla C ^a   Balk, Aggie H M M ^a   Holweg, Cécile T J ^a   Van Riemsdijk, Iza C ^a   Maat, Lex P W M ^a   Vantrimpont, Pascal J M J ^a   Niesters, Hubert G M ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; DNA; IMMUNOSUPPRESSIVE AGENT; STEROID; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE SEQUENCE; GENETIC RISK; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS;

ADULT; CYCLOSPORINE; FEMALE; GENOTYPE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; LEUCINE; MALE; MIDDLE AGE; POLYMORPHISM (GENETICS); PROLINE; SEQUENCE ANALYSIS, DNA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033796869     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00155-8     Document Type: Article

References (23)

1. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The registry of the international society for heart and lung transplantation: sixteenth official report 1999;18:611-6.
2. Kahan BD. An immunosuppresive triumvirate to minimize renal injuries associated with. Transplantation 1999;68:12-4.
3. Gelder van T, Balk AHMM, Zietse R, Hesse CJ, Mochtar B, Weimar W. Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 1998;13:2322-6.
4. Myers B.D., Ross J.C., Newton L.D., Luetscher J.A., Perlroth M.G. Cyclosporin-associated chronic nephropathy. N Engl J Med. 311:1984;699-705.
5. Border W.A., Noble N.A. Transforming growth factor β in tissue fibrosis. New Engl J Med. 331:1994;1286-1292.
6. Pankewycz O.G., Miao L., Isaacs R., et al. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int. 50:1996;1634-1640.
7. Suthanthiran M., Khanna A., Cukran D., et al. Transforming growth factor-β1 hyper expression in African American end-stage renal disease patients. Kidney Int. 53:1998;639-644.
8. Nicholson M.L., Bicknell G.R., Barker G., Doughman T.M., Williams S.T., Furness P.N. Intragraft expression of transforming growth factor-β1 gene in isolated glomeruli from human renal transplants. Br J Surg. 86:1999;1144-1148.
9. Shin G.T., Khanna A., Ding R., et al. In vivo expression of transforming growth factor-β1 in humans stimulation by cyclosporin . Transplantation. 65:1998;313-318.
10. Khanna A., Kapur S., Sharma V., Li B., Suthantriran M. In vivo hyperexpression of transforming growth factor-β1 in mice stimulation by cyclosporin . Transplantation. 63:1997;1037-1039.
11. Shihab F.S., Andoh T.F., Tanner A.M., et al. Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy. Kidney Int. 49:1996;1141-1151.
12. Khanna A.K., Cairns V.R., Becker C.G., Hosenpud J.D. Transforming growth factor (TGF)-β mimics and anti-TGF-β antibody abrogates the in vivo effects of cyclosporin. Transplantation. 67:1999;882-889.
13. Yamada Y., Miyauchi A., Goto J., et al. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res. 13:1998;1569-1576.
14. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., Hutchinson I.V. Genotypic variation in the transforming growth factor-beta 1 gene association with transforming growth factor beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation . Transplantation. 66:1998;1014-1020.
15. El-Gamel A., Awad M.R., Hasleton P.S., et al. Transforming growth factor-beta (TGF-β1) genotype and lung allograft fibrosis. J Heart Lung Transplant. 18:1999;517-523.
16. Cambien F., Ricard S., Troesch A., et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l ' Infartus du Myocarde (ECTIM) study. Hypertension. 28:1996;2281-2287.
17. Wang X.L., Sim A.S., Wilcken D.E.L. A common polymorphism of the transforming growth factor-β1 gene and coronary artery disease. Clin Sci (Colch). 95:1998;745-746.
18. Syrris P., Carter N.D., Metcalfe J.C., et al. Transforming growth factor-beta 1 gene polymorphisms and coronary artery disease. Clin Sci (Colch). 95:1998;659-667.
19. Holweg CTJ, Baan CC, Niesters HGM, et al. TGF-β1 gene polymorphisms in patients with end-stage heart failure. Submitted.
20. Boom R., Sol C.J., Salimans M.M., et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 28:1990;495-503.
21. Perry C., Pravica V., Sinnott P.J., Hutchinson I.V. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes a technical report . Transpl Immunol. 6:(3):1998;193-197.
22. Border W.A., Noble N.A. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension. 3:1998;181-188.
23. Densem C.G., Hutchinson I.V., Yonan N., Brooks N.H. TGF-β gene polymorphism does not influence the rise in creatinine following cardiac transplantation. Transplant Immunol. 7:1999;247-249.